Bipolar I or Bipolar II

This multicenter, randomized, double-blind, placebo-controlled, parallel-group fixed-dose study aims to evaluate the efficacy, safety, and tolerability of an investigational treatment in subjects experiencing depressive episodes associated with Bipolar I or II disorder. Bipolar disorder is characterized by extreme mood swings, including episodes of depression that can significantly affect an individual’s daily functioning and quality of life. The study seeks to determine whether the investigational treatment can provide effective relief from depressive symptoms compared to a placebo, while also assessing its safety and tolerability in participants. By examining these factors, this research aims to contribute valuable insights into potential treatment options for individuals struggling with the challenges of bipolar disorder.